AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06654258 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Spiritual Self-Care Smartphone App
Description: Participants will be asked to engage with a commercially available spiritual self-care smartphone app on a daily basis for 6 weeks. The content spans several domains, including meditation, prayer, affirmations, movement (i.e., stretching and yoga), and music. The user experience is highly personalized, allowing the user to select content that matches their current: mood or needs (e.g., anxiety, loneliness, stress, self-esteem, and sleep), time of day (e.g., recommendations for morning and evening practices), and/or availability (e.g., very brief micro-interventions lasting no more than 90 seconds or longer activities up to 30 minutes in duration). The content is delivered via a combination of audio and visual modalities on a personal smartphone that can be toggled on and off to adjust to surroundings.
Study NCT05881460 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active vibrotactile coordinated reset
Description: Vibrotactile Coordinated Reset delivers vibratory stimulation to the fingertips of each hand. A specific pattern of vibration to each fingertip is delivered which theoretically disrupts abnormal synchrony in the brain.
Study NCT05881460 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham vibrotactile coordinated reset
Description: Vibrotactile Coordinated Reset delivers vibratory stimulation to the fingertips of each hand. An inactive pattern of vibration to each fingertip is delivered which theoretically will not have the effects of active vCR.
Study NCT06659627 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Aerobic exercise therapy
Description: Participants will follow an aerobic exercise therapy program for 16 weeks.
Study NCT06659627 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Cognitive behavioural therapy
Description: Participants will follow an cognitive behavioural therapy program for 12-16 weeks.
Study NCT06659627 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Usual care
Description: Participants do not follow a program, but continue with care as usual
Study NCT03901534 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP) therapy
Description: Standard, clinically used CPAP therapy. CPAP will be prescribed by the participants' clinician provider and not by the study investigators.
Study NCT03901534 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nox A1 Recorder
Description: Non-invasive, body-worn, sleep recording device for nocturnal polysomnography.
Study NCT06660433 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Point-of-care respiratory test platform
Description: A point-of-care respiratory multiplex testing platform situated within a long-term care facility to provide rapid test results
Study NCT04931680 — intervention group
Intervention type: OTHER
Intervention: Data collection
Description: During the follow-up consultation, six weeks after inclusion (S6), data will be collected using a standardized digital questionnaire, including clinical features, economic, social and cultural characteristics, housing conditions and therapeutic details (type of environmental decontamination and treatment received). Data will then be compared between patients with therapeutic success or failure. A urine test strip will also be used during the S6 consultation to screen for proteinuria. The prevalence of post-streptococcal glomerulonephritis will be extrapolated from that of proteinuria.
Study NCT04744662 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ONL1204 Ophthalmic solution
Description: Liquid formulation administered by intravitreal (IVT) injection
Study NCT06660433 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Existing respiratory virus testing platform
Description: Currently used respiratory virus testing platforms
Study NCT06608472 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: N0877
Description: 1 tablet of N0877 and 1 tablet of Placebo of Benicar HCT®
Study NCT06608472 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Benicar HCT ® Tablets 40 mg/25 mg
Description: 1 tablet of Benicar HCT® and 1 tablet of Placebo of N0877
Study NCT06591286 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RT-CGM
Description: This group of patients will wear RT-CGM for blood glucose monitoring for three months.
Study NCT06591286 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: SMBG
Description: This group of patients will use a a fingertip glucose meter for blood glucose monitoring for three months, and the monitoring frequency was not less than 4 times per week.
Study NCT06462716 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BY101298 Capsules
Description: An oral DNA-PK Inhibitor
Study NCT06608368 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Test Dentifrice (Sensodyne Repair and Protect Original Mint)
Description: Dentifrice containing 5% w/w NovaMin (Calcium Sodium Phosphosilicate) and 1040 ppm fluoride as sodium fluoride.
Study NCT06608368 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Positive Control Dentifrice (Sensodyne Fresh Mint)
Description: Dentifrice containing 5% w/w KNO3 and 1150 ppm fluoride as sodium fluoride.
Study NCT06608368 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Reference Dentifrice (Crest Cavity Protection Regular)
Description: Dentifrice containing 1100 ppm fluoride as sodium fluoride.
Study NCT06587308 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dorsal-Double-Layered 10% Circumferential Reduction (DD-10) Pressure Garment
Description: During Phase IA, i.e., the first four weeks between Time 1 (Baseline) and Time 2 (Week 4), when participants are hospitalized in the rehabilitation department of the hospital. participants will need to wear the DD-10 pressure garment for 3 hours in the morning, 3 hours in the afternoon, and 8 hours at night daily. Additionally, all participants will need to attend an occupational therapy session for 30 minutes, 5 days a week. During Phase IB, i.e., the second four weeks between Time 2 (Week 4), and Time 3 (Week 8), when participants were being discharged from the hospital, they need to continually wearing the pressure garment according to same wearing schedule; however, the participants will not need to attend the occupational therapy session.
Study NCT06587308 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Single-Layered 10% Circumferential Reduction (S-10) Pressure Garment
Description: During Phase IA, i.e., the first four weeks between Time 1 (Baseline) and Time 2 (Week 4), when participants are hospitalized in the rehabilitation department of the hospital. participants will need to wear the S-10 pressure garment for 3 hours in the morning, 3 hours in the afternoon, and 8 hours at night daily. Additionally, all participants will need to attend an occupational therapy session for 30 minutes, 5 days a week. During Phase IB, i.e., the second four weeks between Time 2 (Week 4), and Time 3 (Week 8), when participants were being discharged from the hospital, they need to continually wearing the pressure garment according to same wearing schedule; however, the participants will not need to attend the occupational therapy session.
Study NCT06587308 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Single-Layered No Circumferential Reduction (S-0) Pressure Garment
Description: During Phase IA, i.e., the first four weeks between Time 1 (Baseline) and Time 2 (Week 4), when participants are hospitalized in the rehabilitation department of the hospital. participants will need to wear the S-0 pressure garment for 3 hours in the morning, 3 hours in the afternoon, and 8 hours at night daily. Additionally, all participants will need to attend an occupational therapy session for 30 minutes, 5 days a week. During Phase IB, i.e., the second four weeks between Time 2 (Week 4), and Time 3 (Week 8), when participants were being discharged from the hospital, they need to continually wearing the pressure garment according to same wearing schedule; however, the participants will not need to attend the occupational therapy session.
Study NCT06047301 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pathways
Description: Delivered by a nurse or other healthcare provider, includes 2 in-person sessions, and phone check-ins, and occurs primarily during infusion visits. Includes a Pathways Toolkit with handouts on values and goal setting, as well as resources on symptom management, lung cancer stigma, communication strategies, and other cancer center resources.
Study NCT06047301 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Usual Care
Description: Pathways Toolkit handouts on symptom management, lung cancer stigma, communication strategies, and other cancer center resources provided to participants. The Toolkit will be reviewed with patients in person to orient them to its purpose and contents.
Study NCT05220631 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Technology intervention
Description: Older Adult Technology Services (OATS) 5-week technology intervention
Study NCT05220631 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Technology intervention
Description: Older Adult Technology Services (OATS) 5-week technology intervention
Study NCT05220631 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Nutrition Intervention
Description: 15-week nutrition intervention delivered completely online
Study NCT05220631 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Digital Nutrition Intervention
Description: 15-week nutrition intervention delivered completely online
Study NCT05184478 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Medicinal cannabis (MC): THC 10mg/mL : CBD 15mg/mL, manufactured by Cann Group Ltd.
Description: Each 1mL contains 10mg tetrahydrocannabinol (THC),15 mg cannabidiol (CBD), and 0.004mL peppermint oil in medium chain triglyceride (MCT) oil.~All participants will start at 0.1 mL per day, and will gradually increase in 0.1mL increments until day 21 when a dose of 0.5mL (participants weighing \<50kg) or 1mL (participants weighing ≥50kg) is reached. At day 29, an assessment of treatment response will be conducted. Participants who meet criteria for a treatment response will remain on the same dose for the remainder of the treatment period. Participants who do not meet criteria for a treatment response will gradually increase the dose in 0.1mL increments until day 49 when a daily dose of 1mL (participants weighing \<50kg) or 2mL (participants ≥50kg) is reached.
Study NCT05184478 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: The placebo contains MCT oil and peppermint flavoring solution, which is indistinguishable from the active medication in appearance, smell and taste.~The dose will be matched for volume to the medicinal cannabis, and will follow the same dosing schedule as the medicinal cannabis treatment phase.
Study NCT05891561 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pertuzumab
Description: 4 cycles of taxane, pertuzumab, trastuzumab
Study NCT06546826 — intervention group
Intervention type: PROCEDURE
Intervention: BARP
Description: deep layers of collagen, medium-superficial heterologous bone graft, superficial collagen layer
Study NCT06546826 — intervention group
Intervention type: PROCEDURE
Intervention: simple tooth extraction
Description: tooth extraction without grafting procedure.
Study NCT06546826 — intervention group
Intervention type: PROCEDURE
Intervention: tooth root and PRF
Description: Autogenous roots derived from the extracted hopeless tooth and stabilized with osteosynthesis screws to reconstruct the missing buccal wall of the socket. The defect was then filled with PRF.
Study NCT06546826 — intervention group
Intervention type: PROCEDURE
Intervention: Ice cream cone technique
Description: xenogeneic granules and a resorbable collagen membrane
Study NCT06621914 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BFR 80
Description: The intervention involves placing a pneumatic tourniquet system over the proximal thigh. The cuff is inflated to 80% of limb occlusion pressure during lower limb strengthening exercises. These exercises include leg press and knee extensor exercises. Four sets (30,15,15,15 repetitions) performed at 20% of one repetition maximum.
Study NCT06621914 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: BFR40
Description: The intervention involves placing a pneumatic tourniquet system over the proximal thigh. The cuff is inflated to 40% of limb occlusion pressure during lower limb strengthening exercises. These exercises include leg press and knee extensor exercises. Four sets (30,15,15,15 repetitions) performed at 20% of one repetition maximum.
Study NCT06622070 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SPY002-072
Description: Experimental
Study NCT06622070 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05079516 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Theta burst transcranial magnetic stimulation
Description: Real or sham continuous theta burst TMS (cTBS) will be delivered to a location on the head, determined by randomized group assignment. cTBS consists of 600 low-intensity TMS pulses delivered over 40 seconds in a pattern of 50 Hz triplets delivered at 5 Hz.
Study NCT05079516 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Theta burst transcranial magnetic stimulation
Description: Real or sham continuous theta burst TMS (cTBS) will be delivered to a location on the head, determined by randomized group assignment. cTBS consists of 600 low-intensity TMS pulses delivered over 40 seconds in a pattern of 50 Hz triplets delivered at 5 Hz.
Study NCT06120777 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: INVSENSOR00069
Description: Noninvasive pulse oximeter
Study NCT06685640 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: prefabricated stainless steel crowns
Description: Full coverage restoration after pulpal treatment in multi-surface deep caries of primary mandibular second molars requiring pulpotomy
Study NCT06685640 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: prefabricated zirconia crowns
Description: Full coverage restoration after pulpal treatment in multi-surface deep caries of primary mandibular second molars requiring pulpotomy
Study NCT06687681 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: NK cell therapy
Description: Active NK cell injection through lumbar puncture in patient with Astrocytoma IDH-mutant, Oligodendroglioma IDHmutant, Glioblastoma IDH-wild type, Diffuse midline glioma, Diffuse hemispheric glioma, Diffuse pediatrictype high-grade glioma IDH-wild type
Study NCT05726591 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EA-KAFO
Description: This study tests a single device that contains multiple potential configurations as outlined in Table 1 of the protocol. Each participant be evaluated in multiple configurations, minimally including the baseline configuration and the motor assist condition at the knee.
Study NCT06690814 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ficus septica exudate (antiseptic plant exudates)
Description: F. septica sap contains the antibacterial alkaloid ficuseptine which exhibits activivity agaisnt S. pyogenes and H. ducreyi, two pàthogens associated with cutaneous ulcer disease in Papau New Guinea. The sap has been tested using the Ames test for mutagenesis, and found to be non-mutagenic; testing was carried out by toxicology service provider Gentronix, UK (results available separately on request).
Study NCT06690814 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pterocarpus indicus exudate
Description: P. indicus sap exhibits antibacterial activivity agaisnt S. pyogenes, a pàthogen associated with cutaneous ulcer disease in Papau New Guinea. The sap has been tested using the Ames test for mutagenesis, and found to be non-mutagenic; testing was carried out by toxicology service provider Gentronix, UK (results available separately on request).
Study NCT06690814 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Curcuma longa aqueous extract
Description: C. longa is a culinary herb that contains the antibatieral compound curcumin. Curcumin exhibits antibacterial activity agasint S. pyogenes and has profound effects on bacterial biofilms. This intervention uses a mulch of the rhizome that has been sqeeezed to produce a curcumin containing aqueous fluid.
Study NCT06690814 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Savlon antiseptic cream (cetrimide with chlorhexidine digluconate)
Description: Common over the counter antiseptic cream
Study NCT06701578 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Safe and Sound Protocol
Description: Listening to specially designed filtered and modulated music that is tailored to enhance the individual's auditory system's ability to process and respond to auditory stimuli for up to five hours.
Study NCT06701578 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Listening to music that is not filtered and modulated for up to five hours.
Study NCT06708533 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Activity
Description: This intervention involves a structured 12-week walking program designed to increase routine physical activity among participants diagnosed with IBS. The intervention focuses on moderate-intensity walking, performed regularly, in line with World Health Organisation (WHO) guidelines with the aim of relieving IBS symptoms.~Key elements include:~Participants will be guided to adhere to an individualised walking protocol, ensuring consistency in activity levels.~Physical activity levels will be monitored using self-reported diaries and wearable activity trackers to ensure compliance.~Participants will also attend three scheduled visits to the university (baseline, week 6, and week 12) for biological sample collection, sub-maximal fitness assessments, and the completion of validated questionnaires on IBS symptoms, quality of life (QoL), anxiety, and depression.
Study NCT06707012 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin Hydrochloride
Description: Participants will be divided in 2 groups~1 group will receive metformin and 2nd group will receive placebo
Study NCT06707012 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Metformin Hydrochloride
Description: Participants will be divided in 2 groups~1 group will receive metformin and 2nd group will receive placebo
Study NCT06706765 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Treatment
Description: Behavioral cough suppression therapy delivered in a group setting via telehealth.
Study NCT06707831 — intervention group
Intervention type: OTHER
Intervention: Teleassessment
Description: Children underwent assessments on two occasions: one in face-to-face within a clinical setting, and the other through teleassessment using video conferencing. This video conference session was recorded to be later reviewed and scored by two separate raters.
Study NCT06710639 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health Education Program
Description: Instructions and recommendations will be provided in an informational leaflet to encourage an active and healthy lifestyle, promoting self-care and good health practices. This leaflet will include the new WHO guidelines recommending specific measures to reduce the risk of cognitive impairment.
Study NCT06710639 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Training Program
Description: The cognitive training program (CT) focused on everyday cognition (EC) will be conducted individually. Each participant will receive a dossier specifically designed for the study.
Study NCT06708039 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mobile Instant Messaging Application based Self-management and Exercise Programme (SMEP)for Older Adults with Chronic Knee Pain.
Description: The Mobile Instant Messaging Application based self-management and exercise programme (SMEP) consists of 10 short videos of self-management on chronic knee pain in older adults (5-10 minutes/video), 10 short videos of exercise interventions (5-10 minutes/video) and group discussions (10-20 minutes/session) with each video/session focusing on different content. A WhatsApp group that includes all participants in the intervention group will be created to deliver the three components of the program twice a week for five weeks. At the end of each session, they will be given the power point slides from the self-management video in Pdf format and an e-pamphlet of the exercise video. A total of 30-40 minutes will be allocated for each session to allow for socialization between the participants and researcher and also for a question and answer session.
Study NCT06709313 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chromium
Description: Participants in the experimental group will receive oral chromium supplementation, the dosage of which is determined based on previous studies(200 mcg daily) taking into account safety and efficacy considerations. The supplementation will commence for 45 days following the injection.
Study NCT06710600 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Single oral dose of selected medicines, respectively
Description: amiodarone (Amiodaron Arcana) 200mg, diclofenac (Diclobene) 100mg, hydrochlorothiazide (HCT G.L) 25mg, pantoprazole (Pantoloc) 40mg, voriconazole (Voriconazol Aristo®) 200mg
Study NCT06710600 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: UVA and UVB radiation
Description: The skin of the inner arm will be exposed to five fixed incremental doses of UVA and UVB. Each dose will be applied to a circular area on the inner forearm of 1 cm diameter for both UVA and UVB.
Study NCT06710600 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Single oral dose of selected medicines, respectively
Description: acetylsalicylic acid (ASS Genericon) 500mg, doxycycline (Doxybene) 200mg, enalapril (Enalapril ratiopharm) 10mg, furosemide (Lasix) 40mg, verapamil (Verapabene) 80mg